A cost/efficacy analysis of oral antifungals indicated for the treatment of onychomycosis: Griseofulvin, itraconazole, and terbinafine

American Journal of Managed Care

Volumn 3, Issue 3, 1997, Pages 443-450

  Angello, James T ^a,b,c   Voytovich, Robert M ^b   Jan, Saira A ^a,b,c  

^a RUTGERS UNIVERSITY   (United States)

^b HIP Health Plan of New Jersey   (United States)

^c NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOTRANSFERASE; ANTIFUNGAL AGENT; GRISEOFULVIN; ITRACONAZOLE; NAPHTHALENE DERIVATIVE; TERBINAFINE;

ARTICLE; BLOOD; COST BENEFIT ANALYSIS; DIAGNOSIS, MEASUREMENT AND ANALYSIS; DRUG COST; DRUG INTERACTION; ECONOMICS; HEALTH MAINTENANCE ORGANIZATION; HUMAN; ONYCHOMYCOSIS; OUTCOME ASSESSMENT; PATHOPHYSIOLOGY; RECURRENT DISEASE; STATISTICS; UNITED STATES;

ANTIFUNGAL AGENTS; COST-BENEFIT ANALYSIS; DRUG COSTS; DRUG INTERACTIONS; GRISEOFULVIN; HEALTH MAINTENANCE ORGANIZATIONS; HUMANS; ITRACONAZOLE; LABORATORY TECHNIQUES AND PROCEDURES; NAPHTHALENES; NEW JERSEY; ONYCHOMYCOSIS; OUTCOME ASSESSMENT (HEALTH CARE); RECURRENCE; TRANSAMINASES;

EID: 0031090149     PISSN: 10880224     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Habit P. Onychomycosis. In: Trumbold C, Gunter A, ed. Clinical Dermatology. A Color Guide to Diagnosis and Therapy. 3rd ed. St. Louis, MO: Mosby-Year Book, Inc.; 1996:765-769.
2. Summerbell RC, Kane J, Krajden S. Onychomycosis, tinea pedis, and tinea manuum caused by non-dermatophyte filamentous fungi. Mykosen 1989;32:609-619.
3. Midgely G, Moore MK, Cook JC, et al. Mycology of nail disorders. J Am Acad Dermatol 1994;31(suppl):S68-S81.
4. Achten G, Wanet-Rouard J. Onychomycosis in the laboratory. Mycoses 1978;21(suppl 1):124-127.
5. Al-Sogair SM, Moawad MK, Al-Humaidan YM. Fungal infections as a cause of skin disease in the eastern province of Saudi Arabia: Prevailing fungi and pattern of infection. Mycoses 1991;34:333-337.
6. Physicians' Desk Reference. 50th ed. Montvale, NJ: Medical Economics Co;1996.
7. Drug Facts and Comparisons. Philadelphia, PA: JB Lippincott Company;1996.
8. De Doncker P, Williams J, Willemsen M, et al. Post-treatment itraconazole levels in the nail: New implications for treatment in onychomycosis. J Am Acad Dermatol 1992;26(5 pt 1);731-735.
9. De Doncker P, Decroix J, Pierard GE, et al. Antifungal pulse therapy for onychomycosis. A pharmacokinetic and pharmacodynamic investigation of monthly cycles of 1-week pulse therapy with itraconazole. Arch Dermatol 1996;132:34-41.
10. Hay RJ, Baran R, Moore MK, et al. Candida onychomycosis - an evaluation of the role of Candida species in nail disease. Br J Dermatol 1988;118:47-58.
11. Clayon YM, Moore MK, Miagely G, Hay RJ, et al. An evaluation of itraconazole in the management of onychomycosis. Br J Dermatol 1988;119:359-366.
12. Rongioliti F, Robert E, Tripodi S, et al. Treatment of onychomycosis with itraconazole. Dermatological Treatment 1992;2:145-146.
13. DeDoncker P, Scher R, Baran R, et al. Efficacy of itraconazole in the treatment of nondermatophyte onychomycosis of the toenail. Presented at the American Academy of Dermatology 54th Annual Meeting; February 10-15, 1996; Washington, DC.
14. Scher RK, Barnett JM. Successful treatment of Aspergillus flavus onychomycosis with oral itraconazole. J Am Acad Dermatol 1990;23:749-750.
15. Faergemann J, Zehender H, Millerioux L. Levels of terbinafine in plasma, stratum corneum, dermis-epidermis (without stratum corneum), sebum, hair and nails during and after 250 mg terbinafine orally once daily for 7 and 14 days. Clin Exp Dermatol 1994;19:121-126.
16. Brautigam M, Weidinger G, Nolting S, et al. Terbinafine in onychomycosis with involvement by non-dermatophyte fungi. Br J Dermatol 1994;130(suppl 43):16-21.
17. Drug Topics Redbook. Montvale, NJ: Medical Economics Data; 1996.
18. Faergemann J, Anderson C, Hersle K, et al. Double-blind, parallel-group comparison of terbinafine and griseofulvin in the treatment of toenail onychomycosis. J Am Acad Dermatol 1995;32(suppl 5, pt 1):750-753.
19. Walsoe I, Stangerup M, Svejgaard E. Itraconazole in onychomycosis. Open and double-blind studies. Acta Derm Venereol 1990;70:137-140.
20. Hofmann H, Brautigam M, Weidinger G, Zaun H. Treatment of toenail onychomycosis. A randomized, double-blind study with terbinafine and griseofulvin. Arch Dermatol 1995;131:919-922.
21. Piepponen T, Blomqvist K, Brandt H, et al. Efficacy and safety of itraconazole in the long-term treatment of onychomycosis. J Antimicrob Chemother 1992;29:195-205.
22. Svejgaard E. Oral ketoconazole as an alternative to griseofulvin in recalcitrant dermatophyte infections and onychomycosis. Acta Derm Venereol Suppl (Stockh) 1985;65:143-149.
23. Van der Schroeff JG, Cirkel PK, et al. A randomized treatment duration-finding study of terbinafine in onychomycosis. Br J Dermatol 1992;126(suppl 39):36-39.
24. Davies RR, Everall JD, Hamilton E. Mycological and clinical evaluation of griseofulvin for chronic onychomycosis. Br Med J 1967;3:464-468.
25. Korting HC, Schafer-Korting M, Zienicke H, Georgii A, Ollert MW. Treatment of tinea unguium with medium and high doses of ultramicrosize griseofulvin compared with itraconazole. Antimicrob Agents Chemother 1993;37:2064-2068.
26. Arenas R, Dominguez CJ, Fernandez L. Open randomized comparison of itraconazole versus terbinafine in onychomycosis. Int J Dermatol 1995;34:138-143.
27. Braütigam M, Nolting S, Schopf RE, Weidinger G. Randomised double blind comparison of terbinafine and itraconazole for treatment of toenail tinea infection. Br Med 1995;311:919-922.
28. De Backer M, De Keyser P, De Vroey, Lesaffre E. A 12-week treatment for dermatophyte toe onychomycosis: terbinafine 250 mg/day vs. itraconazole 200 mg/day - a double-blind comparative trial. Br J Dermatol 1996;134 (suppl 46):16-17. Discussion 38.
29. Tosti A, Piraccini BM, Stinchi C, Venturo N, Bardazzi F, Colombo MD. Treatment of dermatophyte nail infections: An open randomized study comparing intermittent terbinafine therapy with continuous terbinafine treatment and intermittent itraconazole therapy. J Am Acad Dermatol 1996;34:595-600.
30. Haneke E, Tausch I, Brautigam M, Weidinger G, Welzel D. Short-duration treatment of fingernail dermatophytosis: A randomized, double-blind study with terbinafine and griseofulvin. J Am Acad Dermatol 1995;32:72-77.